Neuroretinal atrophy following resolution of macular oedema in retinal vein occlusion.

CONCLUSIONS: In this exploratory analysis, we describe the characteristics of neuroretinal atrophy in RVO eyes with resolved macular oedema after ranibizumab therapy. Our analysis shows significant, predominantly retinal thinning in the IPL to ONL compartment in focal macular areas in 11% of patients with RVO. Eyes with retinal atrophy did not show poorer BCVA outcomes.
PMID: 29511062 [PubMed - as supplied by publisher]

Source: The British Journal of Ophthalmology - March 6, 2018 Category: Opthalmology Authors: Podkowinski D, Philip AM, Vogl WD, Gamper J, Bogunovic H, Gerendas BS, Haj Najeeb B, Waldstein SM, Schmidt-Erfurth U Tags: Br J Ophthalmol Source Type: research